Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 4, 2011
An essential role for the association of CD47 to SHPS-1 in skeletal remodeling
Laura A Maile, Victoria E DeMambro, Christine Wai, et al.
European Journal of Endocrinology
|
August 19, 2008
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials
Camilo Jimenez, Pia Burman, Roger Abs, et al.
Nature Reviews. Endocrinology
|
July 28, 2018
A Consensus Statement on acromegaly therapeutic outcomes
Shlomo Melmed, Marcello D Bronstein, Philippe Chanson, et al.
International Journal of Endocrinology
|
June 28, 2022
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database
Kevin C J Yuen, Anna Camilla Birkegard, Lewis S Blevins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 15, 2003
Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm
David R Clemmons, Kazuo Chihara, Pamela U Freda, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 4, 2005
Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant
Ariel L Barkan, Pia Burman, David R Clemmons, et al.
Gastroenterology
|
February 4, 2015
Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis
William J Sandborn, Brian Bosworth, Salam Zakko, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 2010
A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-gamma nuclear translocation
Masanobu Kawai, Carla B Green, Beata Lecka-Czernik, et al.
Nature Reviews. Endocrinology
|
February 26, 2014
Expert consensus document: A consensus on the medical treatment of acromegaly
Andrea Giustina, Philippe Chanson, David Kleinberg, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2014
Growth hormone should be used only for approved indications
David R Clemmons, Mark Molitch, Andrew R Hoffman, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 4, 2011
An essential role for the association of CD47 to SHPS-1 in skeletal remodeling
Laura A Maile, Victoria E DeMambro, Christine Wai, et al.
European Journal of Endocrinology
|
August 19, 2008
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials
Camilo Jimenez, Pia Burman, Roger Abs, et al.
Nature Reviews. Endocrinology
|
July 28, 2018
A Consensus Statement on acromegaly therapeutic outcomes
Shlomo Melmed, Marcello D Bronstein, Philippe Chanson, et al.
International Journal of Endocrinology
|
June 28, 2022
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database
Kevin C J Yuen, Anna Camilla Birkegard, Lewis S Blevins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 15, 2003
Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm
David R Clemmons, Kazuo Chihara, Pamela U Freda, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 4, 2005
Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant
Ariel L Barkan, Pia Burman, David R Clemmons, et al.
Gastroenterology
|
February 4, 2015
Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis
William J Sandborn, Brian Bosworth, Salam Zakko, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 2010
A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-gamma nuclear translocation
Masanobu Kawai, Carla B Green, Beata Lecka-Czernik, et al.
Nature Reviews. Endocrinology
|
February 26, 2014
Expert consensus document: A consensus on the medical treatment of acromegaly
Andrea Giustina, Philippe Chanson, David Kleinberg, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2014
Growth hormone should be used only for approved indications
David R Clemmons, Mark Molitch, Andrew R Hoffman, et al.
Page
of 12